Ignite Creation Date:
2025-12-24 @ 9:47 PM
Ignite Modification Date:
2026-01-02 @ 2:00 PM
Study NCT ID:
NCT01040832
Status:
COMPLETED
Last Update Posted:
2017-01-30
First Post:
2009-12-29
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
EMD 1201081 in Combination With Cetuximab in Second-Line Cetuximab-Naïve Subjects With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Sponsor:
EMD Serono
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-12
Start Date Type:
None
Primary Completion Date:
2012-01
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2009-12-29
First Submit QC Date:
None
Study First Post Date:
2009-12-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-06-24
Results First Submit QC Date:
None
Results First Post Date:
2014-07-29
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-01-12
Last Update Post Date:
2017-01-30
Last Update Post Date Type:
ESTIMATED